Entity
Description
  • Value proposition

    Chemical tools for bioconjugaison & biodrugs

    McSAF is a Deeptech company specialized in Bio-Organic & Bio-Conjugates Chemistry, developing innovative technologies for improved targeted therapies.
    Its core expertise covers Therapeutic Peptides and Proteins, Antibodies, and Drug Conjugates.
    The team has a strong background in synthetic selective chemistry, and a real expertise in bioconjugation, including specific designs of Antibody Drug Conjugates (ADCs) with own proprietary coupling technology.
    Plus, the company has now a pipeline of three products in oncology incorporating McSAF Inside technology with the ambition to bring new biodrugs on the market solving unmet medical needs.

    Bioconjugation, Biopharmaceuticals, Antibody Drug Conjugates, ADC, and Chemistry

  • McSAF – Deeptech company specialized in Bio-Organic & Bio-Conjugates Chemistry
  • https://mcsaf.fr
  • Website is possibly disabled or domain is for sale
Catalyst interactions
Catalyst TypeTweets Articles
Atlanpole Biotherapies
Atlanpole Biotherapies
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Atlanpole Biotherapies
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

31 May 2022


Social network dynamics
Similar entities
BETA
Loading...
Loading...